SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-099459
Filing Date
2024-09-12
Accepted
2024-09-12 21:45:02
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423876-12_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2423876-12_3seq1.xml 3 5851
  Complete submission text file 0001104659-24-099459.txt   7655
Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 3 | Act: 34 | File No.: 001-42270 | Film No.: 241296325

Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)